 evidence, the study concluded that
MPFF was highly effective in improving leg symptoms,
edema, and QOL in patients with CVD. The RELIEF study
enrolled 4527 patients with CEAP Class C0 to C4. Approximately 40% of patients belonged to CEAP Class C2. Participants were treated for a period of 6 months and had
signiÔ¨Åcant evolving improvement of symptoms, QOL
measured by the CIVIQ